Microbiota restoration therapy (MRT) compositions and methods of manufacture
Microbiota restoration therapy (MRT) compositions (e.g., oral MRT compositions) and methods for manufacturing MRT compositions are disclosed. An example method for manufacturing an MRT composition may include collecting a stool sample, purifying the stool sample to form a purified sample, stabilizing the purified sample to form a stabilized sample, converting the stabilized sample to a solid, adding one or more additives and/or excipients to the solid to form a treatment composition, and encapsulating the treatment composition.
1. An oral microbiota restoration therapy composition, comprising:
a capsule;
a lyophilized material disposed within the capsule, the lyophilized material including fecal-derived microbiota, polyethylene glycol, trehalose, sucrose, and glycerin.
2. An oral microbiota restoration therapy composition, comprising:
a capsule;
a lyophilized material disposed within the capsule, the lyophilized material including fecal-derived microbiota, polyethylene glycol, trehalose, and sucrose.
3. An oral microbiota restoration therapy composition, comprising:
a mechanically milled lyophilized powder, the mechanically milled lyophilized powder including fecal-derived microbiota, polyethylene glycol, and trehalose, wherein the weight percentage of trehalose in the mechanically milled lyophilized powder is greater than the weight percentage of polyethylene glycol in the mechanically milled lyophilized powder.
4. The oral microbiota restoration therapy composition of claim 3 , wherein the mechanically milled lyophilized powder includes 20-30% (w/w) trehalose.
5. The oral microbiota restoration therapy composition of claim 1 , wherein the lyophilized intermediate is a lyophilized product of lyophilizing a processed fecal sample mixed with a lyophilization excipient.
6. The oral microbiota restoration therapy composition of claim 5 , wherein the lyophilization excipient includes polyethylene glycol.
7. The oral microbiota restoration therapy composition of claim 5 , wherein the lyophilization excipient includes about 2.3% polyethylene glycol.
8. The oral microbiota restoration therapy composition of claim 5 , wherein the lyophilization excipient includes trehalose.
9. The oral microbiota restoration therapy composition of claim 5 , wherein the lyophilization excipient includes about 10% trehalose.
10. The oral microbiota restoration therapy composition of claim 5 , wherein the lyophilization excipient includes sucrose.
11. The oral microbiota restoration therapy composition of claim 5 , wherein the lyophilization excipient includes about 10% sucrose.
12. The oral microbiota restoration therapy composition of claim 5 , wherein the lyophilization excipient includes glycerin.
13. The oral microbiota restoration therapy composition of claim 5 , wherein the lyophilization excipient includes about 1% glycerin.
14. The oral microbiota restoration therapy composition of claim 2 , wherein the lyophilized intermediate is a lyophilized product of lyophilizing a processed fecal sample mixed with a lyophilization excipient.
15. The oral microbiota restoration therapy composition of claim 14 , wherein the lyophilization excipient includes polyethylene glycol.
16. The oral microbiota restoration therapy composition of claim 14 , wherein the lyophilization excipient includes about 2.3% polyethylene glycol.
17. The oral microbiota restoration therapy composition of claim 14 , wherein the lyophilization excipient includes trehalose.
18. The oral microbiota restoration therapy composition of claim 14 , wherein the lyophilization excipient includes about 10% trehalose.
19. The oral microbiota restoration therapy composition of claim 14 , wherein the lyophilization excipient includes sucrose.
20. The oral microbiota restoration therapy composition of claim 14 , wherein the lyophilization excipient includes about 10% sucrose.